/100 ug/RQ4824](https://www.ebiomall.cn/images/NSJ/img-RQ4824-1.jpg)
Bcl10 contains a caspase recruitment domain (CARD), and has been shown to induce apoptosis and to activate NF-kappaB. It is reported to interact with other CARD domain containing proteins including CARD9, 10, 11 and 14, which are thought to function as upstream regulators in NF-kappaB signaling. Bcl10 is found to form a complex with MALT1, a protein encoded by another gene known to be translocated in MALT lymphoma. MALT1 and Bcl10 are thought to synergize in the activation of NF-kappaB, and the deregulation of either of them may contribute to the same pathogenetic process that leads to the malignancy. [RefSeq]
Optimal dilution of the Bcl10 antibody should be determined by the researcher.
A synthetic peptide specific to human Bcl10 was used as the immunogen for the Bcl10 antibody.
Store the Bcl10 antibody at -20oC.